Immune response and protection in raccoons (procyon lotor) following consumption of baits containing ONRAB®, a human adenovirus rabies glycoprotein recombinant vaccine

Journal of Wildlife Diseases

Volumn 48, Issue 4, 2012, Pages 1010-1020

  Brown, L J ^a   Rosatte, R C ^a   Fehlner Gardiner, C ^b   Taylor, J S ^a   Davies, J C ^a   Donovan, D ^a  

^a TRENT UNIVERSITY   (Canada)

^b Ottawa Laboratory Fallowfield   (Canada)

Author keywords

Human adenovirus type 5; Immune response; ONRAB ; Oral rabies vaccination; Procyon lotor; Rabies virus challenge; Raccoon; Raccoon rabies

Indexed keywords

ADENOVIRUS VACCINE; GLYCOPROTEIN; RABIES VACCINE; VIRUS ANTIBODY;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; DISEASE CARRIER; FEMALE; HUMAN; HUMAN ADENOVIRUS; IMMUNOLOGY; MALE; ORAL DRUG ADMINISTRATION; RABIES; RABIES VIRUS; RACCOON; VIROLOGY; WILD ANIMAL;

ADENOVIRUSES, HUMAN; ADMINISTRATION, ORAL; ANIMALS; ANIMALS, WILD; ANTIBODIES, VIRAL; DISEASE RESERVOIRS; FEMALE; GLYCOPROTEINS; HUMANS; MALE; RABIES; RABIES VACCINES; RABIES VIRUS; RACCOONS; VACCINES, ADENOVIRUS;

EID: 84867723557     PISSN: 00903558     EISSN: None     Source Type: Journal    
DOI: 10.7589/2012-01-023     Document Type: Article

References (35)

1. ARTOIS, M., C. GUITTRE, I. THOMAS, H. LEBLOIS, B. BROCHIER, and J. BARRAT. 1992. Potential pathogenicity for rodents of vaccines intended for oral vaccination against rabies: A comparison. Vaccine 10: 524-528.
2. BAER, G. M 1988. Oral rabies vaccination: An overview. Reviews of Infectious Diseases 10: S644-S648.
3. BARTLETT, B. L., A. J. PELLICANE, and S. K. TYRING. 2009. Vaccine immunology. Dermatologic Therapy 22: 104-109.
4. BLACKWELL, B. F., T. W. SEAMANS, R. J. WHITE, Z. J. PATTON, R. M. BUSH, and J. D. CEPEK. 2004. Exposure time of oral rabies vaccine baits relative to baiting density and raccoon population density. Journal of Wildlife Diseases 40: 222-229.
5. BROWN, L. J., R. C. ROSATTE, C. FEHLNER-GARDINER, M. K. KNOWLES, P. BACHMANN, J. C. DAVIES, A. WANDELER, K. SOBEY, and D. DONOVAN. 2011. Immunogenicity and efficacy of two rabies vaccines in wild-caught, captive raccoons. Journal of Wildlife Diseases 47: 182-194.
6. CANADIAN COUNCIL ON ANIMAL CARE (CCAC). 2003. Guidelines on: The care and use of wildlife. Canadian Council on Animal Care, Ottawa, Ontario, Canada, 66 pp.
7. DEAN, D. J., M. K. ABELSETH, and P. ATANASIU. 1996. The fluorescent antibody test. In Laboratory techniques in rabies, 4th Edition, F. X. Meslin, M. M. Kaplan and H. Koprowski (eds.). World Health Organization, Geneva, Switzerland, pp. 88-95.
8. DIETZSCHOLD, B., M. TOLLIS, C. E. RUPPRECHT, E. CELIS, and H. KOPROWSKI. 1987. Antigenic variation in rabies and rabies-related viruses: Cross-production independent of glycoproteinmediated virus-neutralizing antibody. Journal of Infectious Diseases 156: 815-822.
9. DOUGLAS, J. T 2007. Adenoviral vectors for gene therapy. Molecular Biotechnology 36: 71-80.
10. ELMGREN, L. D., and A. I. WANDELER. 1996. Competitive ELISA for the detection of rabies virus-neutralizing antibodies. In Laboratory techniques in rabies, 4th Edition, F. X. Meslin, M. M. Kaplan and H. Koprowski (eds.). World Health Organization, Geneva, Switzerland, pp. 200-208.
11. FEDEROFF, N. E 2001. Antibody response to rabies vaccination in captive and free-ranging wolves (Canis lupus). Journal of Zoo and Wildlife Medicine 32: 127-129.
12. Fehlner-Gardiner, C., S. Nadin-Davis, J. Armstrong, F. Muldoon, P. Bachmann, and A. Wandeler. 2008. ERA vaccine-derived cases of rabies in wildlife and domestic animals in Ontario, Canada, 1989-2004. Journal of Wildlife Diseases 44: 71-85.
13. Fehlner-Gardiner, C., R. RUDD, D. DONOVAN, D. SLATE, L. KEMPF, and J. BADCOCK. 2012. Comparing ONRABH and Raboral V-RGH oral rabies vaccine field performance in raccoons and striped skunks, New Brunswick, Canada, and Maine, USA. Journal of Wildlife Diseases 48: 157-167.
14. INSTITUTE FOR LABORATORY ANIMAL RESEARCH (ILAR). 2011. Guide for the care and use of laboratory animals, 8th Edition, National Research Council, National Academies Press, Washington, D.C., 246 pp.
15. KNOWLES, M. K., D. ROBERTS, S. CRAIG, M. SHEEN, S. A. NADIN-DAVIS, and A. I. WANDELER. 2009a. In vitro and in vivo genetic stability studies of a human adenovirus type 5 recombinant rabies glycoprotein vaccine (ONRAB). Vaccine 27: 2662-2668.
16. KNOWLES, M. K., S. A. NADIN-DAVIS, M. SHEEN, R. ROSATTE, R. MUELLER, and A. BERESFORD. 2009b. Safety studies on an adenovirus recombinant vaccine for rabies (AdRG1.3-ONRAB) in target and nontarget species. Vaccine 27: 6619-6626.
17. KNOWLTON, F. F., M. ROETTO, and D. BRIGGS. 2001. Serological responses of coyotes to two commercial rabies vaccines. Journal of Wildlife Diseases 37: 798-802.
18. MAINGUY, J., E. E. REES, P. CANAC-MARQUIS, D. BÉLANGER, C. FEHLNER-GARDINER, G. SÉGUIN, S. LARRAT, S. LAIR, F. LANDRY, and N. CÔTÉ. 2012. Oral rabies vaccination of raccoons and striped skunks with ONRABH baits: Multiple factors influence field immunogenicity. Journal of Wildlife Diseases, 48: 979-990.
19. MOORE, S. M., and C. A. HANLON. 2010. Rabiesspecific antibodies: Measuring surrogates of protection against a fatal disease. PLoS Neglected Tropical Diseases 4: e595.
20. REES, E. E., D. BELANGER, F. LELIEVRE, N. COTE, and L. LAMBOT. 2011. Targeted surveillance of raccoon rabies in Quebec, Canada. Journal of Wildlife Management 75: 1406-1416.
21. ROSATTE, R. C 2011. Evolution of wildlife rabies control tactics. In Research advances in rabies, advances in virus research, Vol. 79, A. C. Jackson (ed.). Academic Press, Elsevier, London, UK, pp. 397-419.
22. ROSATTE, R. C, and K. F. LAWSON. 2001. Acceptance of baits for delivery of oral rabies vaccine to raccoons. Journal of Wildlife Diseases 37: 730-739.
23. ROSATTE, R. C, D. R. HOWARD, J. B. CAMPBELL, and C. D. MACINNES. 1990. Intramuscular vaccination of skunks and raccoons against rabies. Journal of Wildlife Diseases 26: 225-230.
24. ROSATTE, R. C, K. SOBEY, D. DONOVAN, L. BRUCE, M. ALLAN, A. SILVER, K. BENNETT, M. GIBSON, H. SIMPSON, C. DAVIES, A. WANDELER, and F. MULDOON. 2006. Behavior, movements, and demographics of rabid raccoons in Ontario, Canada: Management implications. Journal of Wildlife Diseases 42: 589-605.
25. ROSATTE, R. C, M. ALLAN, P. BACHMANN, K. SOBEY, D. DONOVAN, J. C. DAVIES, A. SILVER, K. BENNETT, L. BROWN, B. STEVENSON, T. BUCHANAN, L. BRUCE, A. WANDELER, C. FEHLNER-GARDINER, A. BERESFORD, A. BEATH, M. ESCOBAR, J. MAKI, and C. SCHUMACHER. 2008. Prevalence of tetracycline and rabies virus antibody in raccoons, skunks, and foxes following aerial distribution of V-RG baits to control raccoon rabies in Ontario, Canada. Journal of Wildlife Diseases 44: 946-964.
26. ROSATTE, R. C, D. DONOVAN, J. C. DAVIES, M. ALLAN, P. BACHMANN, B. STEVENSON, K. SOBEY, L. BROWN, A. SILVER, K. BENNETT, T. BUCHANAN, L. BRUCE, M. GIBSON, A. BERESFORD, A. BEATH, C. FEHLNERGARDINER, and K. LAWSON. 2009a. Aerial distribution of ONRAB baits as a tactic to control rabies in raccoons and striped skunks in Ontario, Canada. Journal of Wildlife Diseases 45: 363-374.
27. ROSATTE, R. C, D. DONOVAN, M. ALLAN, L. BRUCE, T. BUCHANAN, K. SOBEY, B. STEVENSON, M. GIBSON, T. MACDONALD, M. WHALEN, J. C. DAVIES, F. MULDOON, and A. WANDELER. 2009b. The control of raccoon rabies in Ontario Canada: Proactive and reactive tactics, 1994-2007. Journal of Wildlife Diseases 45: 772-784.
28. ROSCOE, D. E., W. C. HOLSTE, F. E. SORHAGE, C. CAMPBELL, M. NIEZGODA, R. BUCHANNAN, D. DIEHL, H. SHIN NIU, and C. E. RUPPRECHT. 1998. Efficacy of an oral vaccinia-rabies glycoprotein recombinant vaccine in controlling epidemic raccoon rabies in New Jersey. Journal of Wildlife Diseases 34: 752-763.
29. RUPPRECHT, C. E., A. N. HAMIR, D. H. JOHNSTON, and H. KOPROWSKI. 1988. Efficacy of a vacciniarabies glycoprotein recombinant virus vaccine in raccoons (Procyon lotor). Reviews of Infectious Diseases 10: S803-S809.
30. RUPPRECHT, C. E., B. DIETZSCHOLD, J. H. COX, and L. G. SCHNEIDER. 1989. Oral vaccination of raccoons (Procyon lotor) with an attenuated (SAD-B19) rabies virus vaccine. Journal of Wildlife Diseases 25: 548-554.
31. SLATE, D., T. ALGEO, K. NELSON, R. CHIPMAN, D. DONOVAN, J. BLANTON, M. NIEZGODA, and C. RUPPRECHT. 2009. Oral rabies vaccination in North America: Opportunities, complexities, and challenges. PloS Neglected Tropical Diseases 3: e549. doi:10.1371/journalpntd.0000549.
32. th Edition, F. X. Meslin, M. M. Kaplan and H. Koprowski (eds.). World Health Organization, Geneva, Switzerland, pp. 181-192.
33. WINKLER, W. G., J. H. SHADDOCK, and L. W. WILLIAMS. 1976. Oral rabies vaccine: Evaluation of its infectivity in three species of rodents. American Journal of Epidemiology 104: 294-298.
34. WORLD HEALTH ORGANIZATION (WHO). 1992. Expert committee on rabies, 8th Report. WHO Technical Report Series, No. 824, Geneva, Switzerland, 84 pp.
35. ZAR, J. H. 1999. Biostatistical analysis. Prentice-Hall, Inc, Upper Saddle River, New Jersey, 663 pp.